Bright Minds Biosciences Ratios (2020-2026) | DRUG

Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter)
17.00M14.07M10.76M8.10M8.09M8.89M7.95M6.84M5.71M5.10M4.95M4.72M4.53M23.14M40.58M38.62M49.62M63.26M146.47M
Equity Average (Quarter)
15.33M25.80M44.85M63.19M63.77M77.22M93.82M182.40M
Invested Capital (Quarter)
8.08M4.92M25.74M25.62M25.97M63.72M62.65M64.89M89.56M98.08M266.73M
Leverage & Solvency
Equity Ratio (Quarter)
0.870.965.095.585.801.521.591.711.461.501.17
Valuation
Enterprise Value (Quarter)
-0.72M-15.77M-15.74M-15.67M-15.57M-8.98M-8.63M-8.66M-8.66M-5.10M-5.02M-5.07M-5.00M-4.26M-4.16M-4.05M-4.19M-60.31M-59.58M-60.58M
Return Ratios
Return on Capital Employed (Quarter)
-9.35%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%